Nature Genet. 29, 465–468 (2001)).
Regrettably, we did not provide acknowledgment of two sources of funding before our paper was published online on 12 November. Full acknowledgment follows.
Acknowledgements
We thank the individuals with Noonan syndrome and their families who participated in this study, the physicians who referred the subjects, X. Song for technical assistance, H. Weinstein for insightful suggestions about the structural analysis, S. Hassan for providing algorithms and programs to carry out the Montre Carlo calculations and for discussions and G. Diaz and Y. Ioannou for reading the manuscript. This work was supported in part by grants from the NIH (to B.D.G., E.L.M. and R.K.) and from the Human Genetics Program at the Albert Einstein College of Medicine (to R.K.). We would like to thank the Birth Defects Foundation (UK) and the British Heart Foundation (PG /98191) for their support of this project.
Additional information
The online version of the original article can be found at 10.1038/ng772
Rights and permissions
About this article
Cite this article
Tartaglia, M., Mehler, E., Goldberg, R. et al. Correction: Mutations in the protein tyrosine kinase gene, PTPN11, cause Noonan syndrome. Nat Genet 29, 491 (2001). https://doi.org/10.1038/ng1201-491c
Issue Date:
DOI: https://doi.org/10.1038/ng1201-491c
This article is cited by
-
Design of novel SHP2 inhibitors using Topomer CoMFA, HQSAR analysis, and molecular docking
Structural Chemistry (2021)
-
Probing the Dynamic Mechanism of Uncommon Allosteric Inhibitors Optimized to Enhance Drug Selectivity of SHP2 with Therapeutic Potential for Cancer Treatment
Applied Biochemistry and Biotechnology (2019)
